Definitive Healthcare Corp. DH
Set alert
1.12 USD 0.00 0.00%
At close · Oct 30
1.10 -0.02 -1.79%
After hours · Oct 30, 7:52 PM ET
1.09 Day range 1.14
0.628 52-week range 2.93
- YTD
- -60.98%
- 1 year
- -58.21%
- Open
- 1.14
- Prev close
- 1.12
- Mkt cap
- 119.55M
- Vol
- 447.91K
- Avg vol
- 626.40K
- EPS
- -1.61
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.09
- High
- 1.14
- Forward P/E
- 13.42
- Beta
- 1.33
- Short ratio
- 4.71
- Inst. own
- 95.44%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 5, 2024
- 50-d avg
- 4.41
- 200-d avg
- 5.36
- 1y target
- 5.25
3M chart
Signals (12)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 19, 2026 | 1 week ago |
| RSI: Overbought | Oct 19, 2026 | 1 week ago |
| SMA: Bullish | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Sep 30, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 17, 2026 | 1 month ago |
| RSI: Overbought | Sep 2, 2026 | 2 months ago |
| RSI: Overbought | Aug 31, 2026 | 2 months ago |
| SMA: Bullish | Aug 25, 2026 | 2 months ago |
| SMA: Bullish | Aug 19, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 19, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 11, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 7, 2026 | 2 months ago |
Key statistics
- Market cap
- 480.58M
- Enterprise value
- 622.31M
- Trailing P/E
- 0.00
- Forward P/E
- 13.42
- PEG ratio
- 0.00
- Price / sales
- 1.88
- Price / book
- 0.95
- EPS (TTM)
- -3.09
- Beta
- 1.33
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -142.38%
- Revenue (TTM)
- 255.85M
- Revenue growth
- -4.00%
- Free cash flow
- 91.06M
- Total cash
- 306.81M
- Total debt
- 257.19M
- Return on equity
- -54.77%
- Shares outstanding
- 115.52M
- Short % of float
- 4.73%
- 50-day average
- 4.41
- 200-day average
- 5.36
Analyst view
Consensus: buy
Buy
Price target (mean) 5.25 +368.7% upside
Now 1.12
- Target (low)
- 4.00
- Target (mean)
- 5.25
- Target (high)
- 7.00
Ratings (0m) 14 4 buy · 9 hold · 1 sell
- Strong buy0
- Buy4
- Hold9
- Sell0
- Strong sell1
Next earnings
Aug 5, 2024
Expected Aug 5, 2024. Consensus EPS estimate 0.0718.
Financials — quick view
DH Revenue — quarterly 55.20M
DH Net income — quarterly -5.42M
DH EPS — quarterly -0.05
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 7, 2024 | Sep 1, 2024 | 0.08 | 0.10 | +0.02 | +25.00% |
| Aug 5, 2024 | Jun 1, 2024 | 0.09 | — | — | — |
| Aug 5, 2024 | Jun 1, 2024 | 0.09 | 0.09 | 0.00 | 0.00% |
| May 7, 2024 | Mar 1, 2024 | 0.08 | — | — | — |
| May 7, 2024 | Mar 1, 2024 | 0.08 | 0.08 | 0.00 | 0.00% |
| Feb 28, 2024 | Dec 1, 2023 | 0.07 | 0.07 | 0.00 | 0.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 20, 2024 | Stephens & Co. | init | — | Equal-Weight |
| Nov 8, 2024 | Needham | reit | — | Hold |
| Sep 17, 2024 | BTIG | init | — | Buy |
| Aug 9, 2024 | Deutsche Bank | main | Hold | Hold |
| Aug 7, 2024 | Barclays | main | Equal-Weight | Equal-Weight |
| Aug 7, 2024 | Baird | main | Neutral | Neutral |
About Definitive Healthcare Corp.
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
- Sector
- Healthcare
- Industry
- Health Information Services
- Country
- United States
- Website
- definitivehc.com
News
- 12 Health Care Stocks Moving In Wednesday's Intraday Session
- Definitive Healthcare Appoints Clay Ritchey CEO, Effective Sept. 8, Succeeding Kevin Coop
- Morgan Stanley Maintains Equal-Weight on Definitive Healthcare, Lowers Price Target to $1.5
- 12 Health Care Stocks Moving In Monday's After-Market Session
- Definitive Healthcare Raises FY2026 Adj EPS Guidance from $0.16-$0.19 to $0.18-$0.20 vs $0.18 Est; Narrows FY2026 Sales Guidance from $220.000M-$226.000M to $220.000M-$222.000M vs $223.449M Est
- Definitive Healthcare Sees Q3 Adj EPS $0.04-$0.05 vs $0.04 Est; Sees Sales $54.000M-$55.000M vs $55.542M Est
- Definitive Healthcare Q2 Adj. EPS $0.05 Beats $0.04 Estimate, Sales $55.195M Miss $55.476M Estimate
- B of A Securities Downgrades Definitive Healthcare to Underperform, Lowers Price Target to $0.7
- Earnings Scheduled For February 26, 2026
- Earnings Scheduled For November 6, 2025
Your note
Sign in to keep a note on DH — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BOOTH RICHARD DOUGLAS | Chief Financial Officer | Stock Award(Grant) | Nov 4, 2024 | 592,759 |
| CHILUKURI SASTRY | Director | Stock Award(Grant) | May 21, 2024 | 70,883 |
| COOP KEVIN | Chief Executive Officer | Stock Award(Grant) | Jul 2, 2024 | 1,356,240 |
| HAMOOD SAMUEL A | Director | Stock Award(Grant) | May 21, 2024 | 95,877 |
| KRANTZ JASON RONALD | Chief Executive Officer | Stock Award(Grant) | Feb 13, 2024 | 1,355,460 |
| LARSEN JILL | Director | Stock Award(Grant) | May 21, 2024 | 58,840 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Advent International LP | 54.10% | 62,493,676 | 259.97M | Sep 29, 2024 |
| Irenic Capital Management LP | 5.55% | 6,413,185 | 26.68M | Sep 29, 2024 |
| Massachusetts Financial Services Co. | 5.24% | 6,053,233 | 25.18M | Sep 29, 2024 |
| Vanguard Group Inc | 4.07% | 4,705,041 | 19.57M | Sep 29, 2024 |
| Blackrock Inc. | 4.03% | 4,652,288 | 19.35M | Sep 29, 2024 |
| Palisade Capital Management, L.P. | 1.99% | 2,294,579 | 9.55M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| MFS New Discovery Fund | 3.20% | 3,696,877 | 15.38M | Aug 30, 2024 |
| Vanguard Total Stock Market Index Fund | 1.31% | 1,511,094 | 6.29M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 1.21% | 1,401,354 | 5.83M | Oct 30, 2024 |
| Vanguard Small-Cap Index Fund | 1.02% | 1,172,660 | 4.88M | Sep 29, 2024 |
| MFS Variable Insurance Trust-MFS New Discovery Series | 0.99% | 1,147,217 | 4.77M | Sep 29, 2024 |
| Pacific Select Fund-Small Cap Growth Portfolio | 0.71% | 824,012 | 3.43M | Sep 29, 2024 |